Authored By: Sarah
15 Jul 2024

 Proteomics Market Size to grow by USD 33999.4 million between 2024-2028

According to a research report “ Proteomics Market” by Product (Reagents, Instruments, Services) End-user (Clinical diagnostics, Drug discovery, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 33999.4 million, at a CAGR of almost 16.83% during the forecast period. The proteomics market is experiencing significant growth due to the rapid advancements in proteomics research. Proteomics, which involves the study of all proteins produced by a cell, tissue, or organism, is being propelled forward by innovations in technologies such as mass spectrometry, chromatography, and bioinformatics. These advancements have resulted in the creation of new protein identification, quantification, and characterization techniques, as well as valuable insights into proteins' roles in health and disease. A major catalyst for market expansion is the emergence of high-throughput proteomics methods, including mass spectrometry-based proteomics and protein microarrays, which enable the analysis of extensive protein datasets with heightened sensitivity and efficiency.

Browse market data tables, figures, and in-depth TOC on “Proteomics Market” by Product (Reagents, Instruments, Services) End-user (Clinical diagnostics, Drug discovery, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Product, the Reagents segment is projected to dominate the market size in 2024

The Proteomics Market represents a significant business opportunity, driven by the increasing demand for large-scale protein identification and quantification. Advanced technologies, such as mass spectrometry and two-dimensional gel electrophoresis, facilitate comprehensive protein analysis, fueling growth in this sector. Additionally, the integration of bioinformatics tools and the rising application scope in fields like drug discovery and diagnostics further bolster market expansion.

By End-user, Clinical diagnostics  segment is expected to hold the largest market size for the year 2024

The Proteomics Market represents a significant business opportunity, driven by the increasing demand for large-scale protein identification and quantification. Advanced technologies, such as mass spectrometry and two-dimensional gel electrophoresis, facilitate comprehensive protein analysis, fueling growth in this sector. Additionally, the integration of bioinformatics tools and the rising application scope in fields like drug discovery and diagnostics further bolster market expansion.

North America is forecasted to hold the largest market size by region in 2024

The Proteomics Market represents a significant business opportunity, driven by the increasing demand for large-scale protein identification and quantification. Advanced technologies, such as mass spectrometry and two-dimensional gel electrophoresis, facilitate comprehensive protein analysis, fueling growth in this sector. Additionally, the integration of bioinformatics tools and the rising application scope in fields like drug discovery and diagnostics further bolster market expansion.

The Proteomics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Agilent Technologies Inc.
  • Applied Biomics Inc.
  • Bio Rad Laboratories Inc.
  • Biognosys AG
  • Bruker Corp.
  • Cell Signaling Technology Inc.
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • DiaSorin Spa
  • F. Hoffmann La Roche Ltd.
  • Geno Technology Inc.
  • HORIBA Ltd.
  • Illumina Inc.
  • Merck KGaA
  • Olink Holding AB
  • Perkin Elmer Inc.
  • Promega Corp.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Proteomics market encompasses innovative technologies and informatics tools used in the analysis of disease mechanisms, protein functions, and the discovery of biomarkers. This field is crucial for personalized medicine, as it enables the identification of modifications, variations, and protein abundances in the proteome. Proteomics technology employs high-throughput analysis, data integration, and multiplexed analysis to enhance resolution and uncover intricacies in birth disorders and genetic disorders. Key proteins, their interactions, and cellular processes are explored to understand networks and interacting partners. Proteomics plays a pivotal role in drug development by identifying therapeutic targets and potential antibodies. Proteomics technology also includes DNA aptamers for specific target recognition. The market for proteomics is driven by the need for reproducibility, scalability, and the discovery of new biomarkers and therapeutic targets.

Market Research Overview

The Proteomics Market encompasses various segments, including Immunoassay reagents, Protein fractionation, Protein microarrays, Electrophoresis, Chromatography, Spectroscopy, Data management, Protein interaction analysis, Protein profiling, Mass spectrometry, and Proteomic technologies. These tools and techniques facilitate the analysis of Proteome, which is crucial for understanding Disease mechanisms, Protein functions, and Personalized medicine. Proteomics research also plays a significant role in Biomarker discovery and Drug development, as therapeutic targets and Biomarkers are often identified through Protein-protein interactions and Proteomics technology. The market also includes services such as X-ray Crystallography, Mass Spectroscopy, Chromatography, and Laboratory Services. Key Industry players invest in Funding for the development and maintenance of Proteomics instruments and tools, including those based on Nanotechnology and Robotics. The market caters to various Sample types and Species, with applications in Clinical diagnosis, Outsourcing, and Research. The Proteomics Market is driven by increasing Healthcare expenditure, Awareness of Birth disorders and Genetic disorders, and the need for high-throughput, Multiplexed analysis, and Scalability in Protein biology research.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio